Neonatal nursing reference: NICU care, assessment, and common conditions

Neonatal nursing is among the most demanding clinical specialties – and for nursing students on a NICU rotation, the learning curve is steep. You’re caring for patients who can’t communicate their distress, whose physiology changes rapidly in the first hours of life, and whose margin for error is narrower than in almost any other setting. This reference covers the core content you need: normal neonatal vital signs, the Ballard Maturational Assessment, gestational age estimation, neonatal jaundice management, the most common NICU conditions with nursing priorities, feeding principles, and NICU-specific care standards. Use it alongside the APGAR score guide, vital signs by age, and pediatric nursing reference for a complete picture of early life assessment.

Neonatal vital signs and normal values

Normal neonatal values differ substantially from pediatric and adult norms – and shift further depending on gestational age, postnatal age, and clinical context. The ranges below reflect term and preterm norms based on NRP guidelines, AAP recommendations, and standard neonatal nursing references (Kenner & Lott, Comprehensive Neonatal Nursing Care, 6th ed.).

The term heart rate of 100–160 bpm is a typical resting range for a settled term neonate. The AHA PALS reference ranges used on our vital signs by age and pediatric nursing reference pages are wider – 100–205 bpm awake and 90–160 bpm asleep – because they span crying and activity as well as rest. The term systolic range is the PALS value for a 3 kg term newborn.

Key clinical note: Respiratory rate is the most sensitive vital sign in neonates. Tachypnea (RR >60) beyond the first hour of life is a red flag for respiratory distress, infection, or metabolic disorder and always requires further assessment.

Initial neonatal assessment

APGAR score

The APGAR score is assessed at 1 and 5 minutes after birth, scoring five parameters – Appearance, Pulse, Grimace, Activity, and Respiration – on a 0–2 scale. A score of 7–10 indicates a vigorous infant; 4–6 indicates moderate depression; 0–3 indicates severe depression requiring immediate resuscitation. See the full APGAR score guide for the scoring table and resuscitation decision tree.

APGAR is a snapshot of transition, not a predictor of long-term outcomes. A low 1-minute score reflects the birth process. A low 5-minute score is more clinically significant and may indicate the need for extended resuscitation efforts under NRP protocols.

Transition to extrauterine life

The first minutes and hours after birth require rapid physiologic adaptation:

Respiratory transition: The fetal lung is fluid-filled. With the first breaths, fluid is absorbed into the lymphatics, surfactant spreads across alveoli, and functional residual capacity is established. Preterm infants have insufficient surfactant – the basis for respiratory distress syndrome (RDS). Signs of failed respiratory transition include persistent grunting, nasal flaring, subcostal and intercostal retractions, and cyanosis.

Circulatory transition: Fetal circulation depends on the ductus arteriosus and foramen ovale to bypass the lungs. With the first breath, pulmonary vascular resistance drops, left atrial pressure rises, and both shunts functionally close. In preterm infants, the ductus arteriosus frequently fails to close spontaneously – this is patent ductus arteriosus (PDA), discussed below.

Thermoregulation

Neonates – particularly preterm infants – are highly vulnerable to hypothermia. They have a large surface-area-to-volume ratio, limited subcutaneous fat, and cannot shiver effectively. Cold stress increases oxygen consumption, glucose utilization, and the risk of metabolic acidosis.

Interventions for thermoregulation:

• Neutral thermal environment (NTE): The ambient temperature range at which the infant maintains normal body temperature with minimal metabolic effort. For preterm infants, this requires a radiant warmer or incubator with servo-controlled temperature set to skin target of 36.5°C.
• Skin-to-skin (kangaroo care): Effective for stable preterm and term infants. Maternal skin temperature regulates infant temperature and provides additional benefits (bonding, breastfeeding, neurodevelopment).
• Plastic wrap / polyethylene bag: For infants <32 weeks, place in a polyethylene bag immediately at delivery (before drying) to reduce evaporative heat loss – an NRP recommendation.
• Warm, humidified incubator: For very low birth weight (VLBW) infants, humidity of 70–80% in the first week reduces insensible water loss and helps maintain temperature.

See head-to-toe assessment for the full neonatal physical exam sequence.

Ballard Maturational Assessment

The New Ballard Score (NBS) estimates gestational age (GA) using six neuromuscular and six physical maturity criteria, each scored from -1 to 5. In the 1991 validation study, infants under 26 weeks were scored most accurately when examined before 12 hours of age; for infants of 26 weeks or more, accuracy held steady for exams done at any point up to 96 hours. Agreement with dates is within about ±2 weeks. It is particularly useful when gestational age is uncertain from maternal history.

Total score ranges from -10 to 50, correlating with gestational ages of approximately 20 to 44 weeks.

Each item is scored from the least mature to the most mature finding. Most items run from -1 to 4; popliteal angle and skin extend to 5, and posture and arm recoil start at 0. Selected landmarks from the official score sheet:

Score-to-age correlation: each 5 points equals 2 weeks. Score -10 ≈ 20 weeks | 0 ≈ 24 weeks | 10 ≈ 28 weeks | 20 ≈ 32 weeks | 30 ≈ 36 weeks | 40 ≈ 40 weeks | 50 ≈ 44 weeks.

Neonatal jaundice and hyperbilirubinemia

Jaundice (icterus neonatorum) affects approximately 60% of term and 80% of preterm neonates in the first week of life. It results from elevated unconjugated (indirect) bilirubin as fetal red blood cells are broken down and the immature liver struggles to conjugate and excrete bilirubin.

Physiologic vs pathologic jaundice

Physiologic jaundice appears after 24 hours of life, peaks around days 3–4 in term infants (days 5–7 in preterm), and resolves by day 10–14. Peak TSB is generally about 12–15 mg/dL or lower in term infants.

Pathologic jaundice is characterized by:

• Jaundice appearing within the first 24 hours of life (always pathologic – evaluate immediately)
• A rapid rate of rise – the AAP 2022 guideline treats ≥0.3 mg/dL per hour in the first 24 hours, or ≥0.2 mg/dL per hour after that, as a sign of possible hemolysis
• Total serum bilirubin (TSB) exceeding age-specific thresholds
• Jaundice persisting beyond 2 weeks (3 weeks in breastfed infants)
• Direct (conjugated) bilirubin >1.0 mg/dL at any TSB level (NASPGHAN/ESPGHAN 2017 dropped the older “>20% of TSB” rule); this suggests hepatobiliary disease and needs urgent evaluation

Common causes of pathologic jaundice: ABO or Rh incompatibility, G6PD deficiency, sepsis, cephalohematoma resorption, polycythemia, congenital hypothyroidism.

Phototherapy thresholds

The AAP 2022 revised guidelines use hour-specific TSB thresholds that rise with gestational age and fall when neurotoxicity risk factors are present. The table below gives the 2022 values for an infant born at 38 weeks, read from the guideline’s threshold curves (via the PediTools implementation). At 40 weeks or more, the no-risk-factor phototherapy thresholds run about 1 mg/dL higher; at 35–37 weeks they are lower.

Escalation of care (urgent NICU-level management while exchange transfusion is prepared) begins when the TSB comes within 2 mg/dL of the exchange transfusion threshold.

*The 2022 AAP guideline defines hyperbilirubinemia neurotoxicity risk factors as: gestational age <38 weeks; albumin <3.0 g/dL; isoimmune hemolytic disease, G6PD deficiency, or other hemolytic condition; sepsis; and any significant clinical instability in the previous 24 hours. Note that the 2022 revision removed race and ancestry from this list. The values above are for teaching. Always use the published AAP 2022 hour-specific curves (or a validated calculator) for the infant’s exact gestational age and age in hours; thresholds are higher under the 2022 guideline than under the 2004 version.

Nursing interventions for hyperbilirubinemia

• Place infant under phototherapy with maximum skin exposure – remove clothing except diaper. The 2022 AAP guideline specifies narrow-spectrum blue LED in the 460–490 nm band (peak near 475 nm); wavelengths outside this range add heat without improving bilirubin clearance
• Cover eyes with phototherapy shields; check every 2–4 hours for correct placement and corneal abrasion
• Monitor temperature during phototherapy – lights increase insensible water loss and can cause hyperthermia or hypothermia
• Increase feeds to every 2–3 hours; frequent feeding promotes bilirubin excretion via stool
• Monitor TSB per protocol: the AAP 2022 guideline calls for a TSB within 12 hours of starting phototherapy, then timing based on age, risk factors, and rate of rise (every 2 hours once TSB is within 2 mg/dL of the exchange threshold)
• Do NOT use sunlight phototherapy – it is inconsistent and carries burn risk

Kernicterus risk: Unconjugated bilirubin crosses the blood-brain barrier and deposits in the basal ganglia and brainstem when TSB exceeds critical thresholds. Acute bilirubin encephalopathy presents with lethargy, poor feeding, hypertonia, and arched posturing (opisthotonus). Kernicterus – permanent bilirubin-induced neurological dysfunction – causes the classic tetrad of choreoathetoid cerebral palsy, auditory neuropathy (hearing loss), upward gaze palsy, and dental enamel dysplasia of the primary teeth (Shapiro 2010). Intellect is often relatively spared. Prevention is the priority. For the full jaundice pathway, see neonatal jaundice nursing.

Common NICU conditions

Respiratory distress syndrome (RDS)

RDS results from surfactant deficiency in preterm lungs. Surfactant (produced by type II pneumocytes, predominantly after 34–36 weeks) reduces alveolar surface tension and prevents collapse. Without adequate surfactant, alveoli collapse on expiration, requiring progressively greater effort to re-inflate.

Signs: Onset within minutes to hours of birth – grunting (auto-PEEP mechanism), nasal flaring, suprasternal, subcostal, and intercostal retractions, tachypnea, cyanosis. CXR shows diffuse ground-glass haziness with air bronchograms.

Management: Exogenous surfactant therapy (beractant, calfactant, poractant alfa) administered via endotracheal tube – Current European consensus (2023) starts CPAP from birth and gives rescue surfactant early when FiO2 rises above 0.30 on CPAP of at least 6 cm H2O. Less invasive surfactant administration (LISA) through a thin catheter is the preferred method for spontaneously breathing infants on CPAP; INSURE (Intubation, Surfactant, Extubation to CPAP) is the older alternative. Continuous positive airway pressure (CPAP) maintains functional residual capacity. Mechanical ventilation for infants who fail CPAP. Antenatal corticosteroids (betamethasone) given to mothers between 24–34 weeks reduce RDS incidence and severity.

Nursing priorities: Monitor respiratory status continuously, titrate oxygen to the unit’s preterm SpO2 target (commonly 90–94% or 90–95%), minimize barotrauma during ventilator management, monitor for complications (air leak syndromes, pulmonary hemorrhage), reposition every 2–4 hours.

Necrotizing enterocolitis (NEC)

NEC is intestinal necrosis affecting predominantly preterm infants – one of the most serious and life-threatening NICU emergencies. Its estimated mortality is 20–30%, highest among infants who need surgery (Neu & Walker 2011). The pathophysiology involves intestinal ischemia, bacterial invasion, and inflammatory cascade in an immature gut.

Risk factors: Gestational age <32 weeks, formula feeding (breast milk is significantly protective), polycythemia, congenital heart disease, infection.

Signs: Abdominal distension (often the first sign), feeding intolerance with increased gastric residuals, bilious gastric aspirates, blood in stool (gross or occult), temperature instability, lethargy, apnea. X-ray finding of pneumatosis intestinalis (gas in the bowel wall) is pathognomonic; pneumoperitoneum indicates perforation.

Nursing priorities: NPO immediately on suspicion, nasogastric decompression, IV antibiotics (broad-spectrum, covering gram-negative organisms and anaerobes), hemodynamic monitoring, strict abdominal girth measurements every 4–8 hours, surgical consultation for perforation or clinical deterioration. Breast milk feeding is the strongest preventive intervention – encourage human milk from the first day of life.

Intraventricular hemorrhage (IVH)

IVH is bleeding into the germinal matrix – a fragile capillary bed adjacent to the lateral ventricles that involutes after 32–34 weeks. It occurs almost exclusively in preterm infants, with incidence inversely proportional to gestational age.

Grading (Papile classification):

• Grade I: Germinal matrix hemorrhage only, no ventricular involvement
• Grade II: Blood in the ventricle without ventricular dilation
• Grade III: Intraventricular hemorrhage with ventricular dilation
• Grade IV: Parenchymal hemorrhage (periventricular hemorrhagic infarction) – highest mortality and morbidity

Grades I and II typically resolve without sequelae. Grades III and IV carry significant risk of post-hemorrhagic hydrocephalus and neurodevelopmental disability.

Risk factors: Extreme prematurity, hemodynamic instability, coagulopathy, rapid volume infusion, pneumothorax, asphyxia.

Nursing priorities: Minimize handling, maintain HOB elevated 30°, avoid rapid fluid boluses, maintain stable blood pressure (avoid swings), cranial ultrasound per protocol (the AAP 2020 clinical report supports routine screening for infants born at or below 30 weeks; unit schedules commonly scan at 7–10 days of life and again at 4–6 weeks), neurodevelopmental follow-up planning.

Patent ductus arteriosus (PDA)

In fetal circulation, the ductus arteriosus connects the pulmonary artery to the aorta, diverting blood away from the fetal lungs. It closes functionally within hours of birth in response to increased oxygen tension and prostaglandin decline. In preterm infants, spontaneous closure is frequently delayed.

Clinical presentation: A hemodynamically significant PDA causes a left-to-right shunt – excess blood recirculates to the lungs. Signs include bounding peripheral pulses, widened pulse pressure, continuous (“machinery”) murmur at the left upper sternal border, worsening respiratory status, and increased ventilator requirements.

Management: Fluid restriction, indomethacin (COX inhibitor, inhibits prostaglandin synthesis) or ibuprofen – both have similar closure rates. Surgical ligation (via thoracotomy or VATS) is reserved for infants who fail medical management or who are not candidates for NSAIDs (renal dysfunction, thrombocytopenia, active bleeding). In the Caffeine for Apnea of Prematurity trial, infants given caffeine citrate needed PDA treatment less often (Schmidt 2006).

Nursing priorities: Assess peripheral pulses and precordial activity at each assessment, monitor for worsening respiratory status, monitor renal function and platelet count during indomethacin/ibuprofen therapy, restrict fluids as ordered, monitor urine output.

Neonatal abstinence syndrome (NAS)

NAS – now more broadly called Neonatal Opioid Withdrawal Syndrome (NOWS) when opioids are the causative agent – occurs in infants born to mothers using opioids or other substances. Per the AAP, withdrawal from heroin often begins within 24 hours of birth, while methadone withdrawal usually starts at 24–72 hours; with either drug, signs may be delayed until 5–7 days of age, often after discharge.

Signs: High-pitched cry, poor feeding, uncoordinated sucking, vomiting, diarrhea, diaphoresis, tremors, myoclonic jerks, hyperthermia, irritability, nasal stuffiness, yawning, sneezing.

Assessment – Finnegan Neonatal Abstinence Scoring System: The modified Finnegan tool has 21 items and is usually scored every 3–4 hours, after feeds. A common Finnegan-based rule starts pharmacologic treatment after three consecutive scores of 8 or more, or two consecutive scores of 12 or more; exact thresholds vary by unit protocol.

Eat, Sleep, Console (ESC): Many units now use this function-based approach instead of Finnegan scoring. The nurse and family assess, against defined criteria, whether the infant can eat effectively, sleep, and be consoled. Nonpharmacologic care is maximized first, and medication is added only when these functions fail despite it. In a 2023 cluster-randomized trial at 26 US hospitals, ESC cut the time until infants were medically ready for discharge from 14.9 to 8.2 days, with similar rates of adverse outcomes over the first 3 months.

Non-pharmacologic comfort measures (first-line):

• Low-stimulation environment: dim lights, minimize noise, cluster care
• Swaddling, non-nutritive sucking (pacifier)
• Small, frequent feeds (high-calorie formula if needed for weight gain)
• Skin-to-skin contact with a calm caregiver
• Vertical rocking, gentle swaying

Pharmacologic treatment: Oral morphine solution or methadone are first-line for opioid withdrawal (AAP clinical report, 2020), titrated by Finnegan score. Phenobarbital may be added for infants not responding to opioid therapy or for polysubstance exposure. Treatment is slowly weaned over days to weeks. See pharmacology study guide for opioid medication reference.

Neonatal feeding

Feeding in the NICU requires individualized assessment – gestational age, oral motor development, respiratory stability, and energy reserves all influence readiness and route.

Breastfeeding in the NICU

Human milk is the gold standard for all neonates, and especially critical for preterm infants. Benefits include reduced NEC risk, lower infection rates, improved neurodevelopmental outcomes, and better feeding tolerance. Encourage mothers to initiate pumping within 1–2 hours of delivery if the infant cannot latch. Target pump frequency is 8+ times per day to establish and maintain supply.

For infants too preterm or medically unstable to breastfeed directly, expressed breast milk (EBM) is administered by gavage (NG or OG tube). As the infant matures, non-nutritive sucking at the breast during tube feeds supports oral motor development and promotes transition to full breastfeeding.

Gavage tube feeds and preterm feeding advancement

• NG (nasogastric) vs OG (orogastric): OG preferred for infants on CPAP (avoids nasal occlusion); NG used when OG is not tolerated.
• Verify placement before each feed: aspirate gastric contents and check pH. A pH of 5 or less supports gastric placement (ASPEN NOVEL pediatric recommendations, Irving 2018). Milk feeds and acid-suppressing drugs often raise neonatal gastric pH above 5, so a higher reading is inconclusive. Confirm with X-ray, the reference standard, when pH is above 5 or the infant is high risk (intubated, sedated, or with a weak gag or cough).
• Feeding advancement: Most centers advance feeds by 10–20 mL/kg/day for VLBW infants (<1,500 g) to reduce NEC risk. Infants >1,500 g may tolerate faster advancement.
• Fortification: Preterm breast milk is insufficient in protein, calcium, and phosphorus to meet the demands of rapid growth. Human milk fortifier (HMF) is added once feeds reach approximately 100 mL/kg/day.
• Feeding readiness cues: Rooting, sucking on hands or pacifier, alertness, hand-to-mouth activity. Signs of feeding intolerance: large gastric residuals (>50% of prior feed volume), bilious aspirates, abdominal distension, apnea/bradycardia during feeds.

Check nursing lab values for glucose and electrolyte monitoring reference during parenteral nutrition.

NICU nursing priorities

Infection prevention

NICU patients are profoundly immunocompromised – preterm infants lack transplacentally acquired maternal antibodies and have an immature innate immune response. Healthcare-associated infections (HAIs) carry significant mortality risk.

• Hand hygiene: 2 minutes surgical scrub technique on NICU entry; alcohol-based gel for subsequent hand hygiene within the unit. This is non-negotiable.
• Central line-associated bloodstream infection (CLABSI) prevention: Daily line necessity review, dressing changes per protocol, chlorhexidine skin antisepsis where benefits outweigh risks (CDC 2022 NICU guidance suggests alcohol-containing chlorhexidine and asks units to weigh gestational age, chronologic age, and skin maturity, because preterm skin is prone to chemical burns), closed IV system, sterile technique for line access.
• Umbilical catheter care: UACs (umbilical arterial catheters) and UVCs (umbilical venous catheters) are common in NICU – high CLABSI risk. Remove as soon as they are no longer needed. CDC guidance: umbilical arterial catheters should optimally stay no longer than 5 days; umbilical venous catheters can be used up to 14 days if managed aseptically.

Developmental care

Premature infants are developmentally programmed to be in utero during a NICU stay. The NICU environment – noise, light, painful procedures, disrupted sleep – can adversely affect neurodevelopment. Developmental care aims to minimize this impact.

• Minimal stimulation: Cluster care activities to allow 3–4-hour sleep periods. Dim lighting during sleep. Shield incubator from noise.
• Positioning: Maintain flexed, midline positioning to replicate in utero posture. Use positioning aids (nesting rolls, gel mattresses). Avoid prolonged head-to-side positioning (increases IVH risk).
• Kangaroo care (skin-to-skin): Strong evidence supports kangaroo care for temperature regulation, physiologic stability, brain development, breastfeeding, and parent bonding. Facilitate for stable preterm infants from the earliest opportunity, including for ventilated infants with careful planning.

Pain assessment

Neonates experience pain but cannot self-report. The Neonatal Infant Pain Scale (NIPS) assesses six indicators: facial expression, cry, breathing pattern, arms, legs, and state of arousal – each scored 0–1 or 0–2. Scores ≥4 indicate significant pain and require intervention. Procedural pain management includes sucrose (24%) with pacifier (effective for minor procedures), non-nutritive sucking, swaddling, skin-to-skin, and opioids/sedation for invasive procedures.

Family-centered care

Parents are integral to NICU care – not visitors. Family-centered care (FCC) is associated with better outcomes and parent mental health. Nursing priorities include:

• Teach parents hands-on care (diaper changes, temperature taking, NG tube feeds) from the first day
• Encourage kangaroo care as early as medically feasible
• Include parents in bedside rounds and clinical discussions
• Provide clear, consistent communication about their infant’s condition and progress
• Screen parents for PTSD, postpartum depression, and anxiety – NICU admission is a traumatic experience for families

Related references

This page is one of a series of clinical reference guides:

• APGAR score guide – full scoring table and NRP resuscitation decision pathway
• Vital signs by age – normal ranges from neonates through adults
• Pediatric nursing reference – assessment, growth and development, common pediatric conditions
• Head-to-toe assessment – full neonatal and pediatric physical exam sequence
• Nursing lab values – complete laboratory reference with critical values
• Pharmacology study guide – drug classifications and NICU medications including NAS pharmacotherapy

References

1. Kemper AR, Newman TB, Slaughter JL, et al. (2022). Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 150(3):e2022058859. doi:10.1542/peds.2022-058859

2. Papile LA, Burstein J, Burstein R, Koffler H. (1978). Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics. 92(4):529–534. doi:10.1016/s0022-3476(78)80282-0

3. Lee HC, Strand ML, Finan E, et al. (2025). Part 5: neonatal resuscitation – 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 152(16_suppl_2):S385–S423. doi:10.1161/CIR.0000000000001367

4. Stoll BJ, Hansen NI, Bell EF, et al. (2010). Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 126(3):443–456. doi:10.1542/peds.2009-2959

5. Neu J, Walker WA. (2011). Necrotizing enterocolitis. New England Journal of Medicine. 364(3):255–264. doi:10.1056/NEJMra1005408

6. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. (1991). New Ballard Score, expanded to include extremely premature infants. Journal of Pediatrics. 119(3):417–423. doi:10.1016/s0022-3476(05)82056-6

7. Bhutani VK, Johnson L, Sivieri EM. (1999). Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 103(1):6–14. doi:10.1542/peds.103.1.6

8. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. (2011). Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Archives of Disease in Childhood – Fetal and Neonatal Edition. 96(1):F45–F52. doi:10.1136/adc.2009.168682

9. Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn. (2012). Neonatal drug withdrawal. Pediatrics. 129(2):e540–e560. doi:10.1542/peds.2011-3212

10. Kenner C, Lott JW, eds. (2019). Comprehensive Neonatal Nursing Care. 6th ed. New York: Springer Publishing.

11. Carlo WA, Finer NN, Walsh MC, et al. (2010). Target ranges of oxygen saturation in extremely preterm infants. New England Journal of Medicine. 362(21):1959–1969. doi:10.1056/NEJMoa0911781

12. Sweet DG, Carnielli VP, Greisen G, et al. (2023). European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 update. Neonatology. 120(1):3–23. doi:10.1159/000528914

13. Schmidt B, Roberts RS, Davis P, et al. (2006). Caffeine therapy for apnea of prematurity. New England Journal of Medicine. 354(20):2112–2121. doi:10.1056/NEJMoa054065

14. Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group. (2005). Neurologic and developmental disability at six years of age after extremely preterm birth. New England Journal of Medicine. 352(1):9–19. doi:10.1056/NEJMoa041367

15. Horbar JD, Carpenter JH, Badger GJ, et al. (2012). Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 129(6):1019–1026. doi:10.1542/peds.2011-3028

16. Cummings JJ, Polin RA; Committee on Fetus and Newborn. (2016). Oxygen targeting in extremely low birth weight infants. Pediatrics. 138(2):e20161576. doi:10.1542/peds.2016-1576

17. Patrick SW, Barfield WD, Poindexter BB; Committee on Fetus and Newborn, Committee on Substance Use and Prevention. (2020). Neonatal opioid withdrawal syndrome. Pediatrics. 146(5):e2020029074. doi:10.1542/peds.2020-029074

18. Young LW, Ounpraseuth ST, Merhar SL, et al. (2023). Eat, Sleep, Console approach or usual care for neonatal opioid withdrawal. New England Journal of Medicine. 388(25):2326–2337. doi:10.1056/NEJMoa2214470

19. O’Grady NP, Alexander M, Burns LA, et al. (2011). Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases. 52(9):e162–e193. doi:10.1093/cid/cir257

20. Chou JH. PediTools: 2022 AAP hyperbilirubinemia guideline thresholds (bili2022). peditools.org. Accessed October 4, 2026.

21. Shapiro SM. (2010). Chronic bilirubin encephalopathy: diagnosis and outcome. Seminars in Fetal and Neonatal Medicine. 15(3):157–163. doi:10.1016/j.siny.2009.12.004

22. Hand IL, Shellhaas RA, Milla SS; Committee on Fetus and Newborn, Section on Neurology, Section on Radiology. (2020). Routine neuroimaging of the preterm brain. Pediatrics. 146(5):e2020029082. doi:10.1542/peds.2020-029082

23. Fawaz R, Baumann U, Ekong U, et al. (2017). Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of NASPGHAN and ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. 64(1):154–168. doi:10.1097/MPG.0000000000001334

24. Centers for Disease Control and Prevention. (2022). Recommendations for prevention and control of infections in neonatal intensive care unit patients: central line-associated blood stream infections. cdc.gov/infection-control/hcp/nicu-clabsi. Accessed October 16, 2026.

25. Adamkin DH; Committee on Fetus and Newborn. (2011). Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 127(3):575–579. doi:10.1542/peds.2010-3851

26. Thornton PS, Stanley CA, De Leon DD, et al. (2015). Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. Journal of Pediatrics. 167(2):238–245. doi:10.1016/j.jpeds.2015.03.057

27. Shaffer SG, Quimiro CL, Anderson JV, Hall RT. (1987). Postnatal weight changes in low birth weight infants. Pediatrics. 79(5):702–705. doi:10.1542/peds.79.5.702

28. Irving SY, Rempel G, Lyman B, Sevilla WMA, Northington L, Guenter P; American Society for Parenteral and Enteral Nutrition. (2018). Pediatric nasogastric tube placement and verification: best practice recommendations from the NOVEL Project. Nutrition in Clinical Practice. 33(6):921–927. doi:10.1002/ncp.10189

29. Kellams A, Harrel C, Omage S, Gregory C, Rosen-Carole C; Academy of Breastfeeding Medicine. (2017). ABM Clinical Protocol #3: supplementary feedings in the healthy term breastfed neonate, revised 2017. Breastfeeding Medicine. 12(4):188–198. doi:10.1089/bfm.2017.29038.ajk

30. Paul IM, Schaefer EW, Miller JR, Kuzniewicz MW, Li SX, Walsh EM, Flaherman VJ. (2016). Weight change nomograms for the first month after birth. Pediatrics. 138(6):e20162625. doi:10.1542/peds.2016-2625

31. National Institute for Health and Care Excellence. (2017). Faltering growth: recognition and management of faltering growth in children. NICE guideline NG75 (recommendations 1.1.1–1.1.5). London: NICE.